RTW BIO completes investment in Arix Bioscience ahead of merger
LONDON, UK: RTW BIO, a biopharmaceutical and medical technology investment company, has completed its investment in Arix Bioscience, a life sciences venture capital firm, ahead...
Depixus raises €30.6 million in Series A Financing
LONDON, UK: Arix Bioscience’s portfolio company Depixus has successfully completed its oversubscribed Series A financing which raised €30.6 million (£26.1 million). Depixus is a biotechnology...
Arix Bioscience founds new portfolio company, Twelve Bio
LONDON: Arix Bioscience Plc, a global venture capital company focused on investing in and building breakthrough biotech companies, announced the foundation of a new portfolio...